Invention Grant
- Patent Title: Xanthine oxidase inhibitor formulations
-
Application No.: US14776905Application Date: 2014-03-17
-
Publication No.: US11406713B2Publication Date: 2022-08-09
- Inventor: Allen Davidoff
- Applicant: Allen Davidoff
- Applicant Address: CA Calgary
- Assignee: Allen Davidoff
- Current Assignee: Allen Davidoff
- Current Assignee Address: CA Calgary
- Agency: Wolter, Van Dyke, Davis, PLLC
- Agent Timothy H. Van Dyke
- International Application: PCT/IB2014/001042 WO 20140317
- International Announcement: WO2014/140868 WO 20140918
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K47/18 ; A61K9/14 ; A61K9/19 ; A61K9/00 ; A61K31/375 ; A61K31/4188 ; A61K31/4415 ; A61K31/714 ; A61K31/455 ; A61K31/525 ; A61K31/51 ; A61K31/593 ; A61K31/197 ; A61K31/198 ; A61J1/00
Abstract:
Disclosed herein are methods and compositions for involving a xanthine oxidase inhibitor that has enhanced solubility. The compositions described herein include a xanthine oxidase inhibitor combined with an organic base. The compositions can be used to treat a disease or medical condition that involves elevated uric acid levels.
Public/Granted literature
- US20160038595A1 XANTHINE OXIDASE INHIBITOR FORMULATIONS Public/Granted day:2016-02-11
Information query
IPC分类:
